<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03731819</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-2018-1276</org_study_id>
    <nct_id>NCT03731819</nct_id>
  </id_info>
  <brief_title>Establishment of Abbreviated Pancreatobiliary MRI Protocol</brief_title>
  <official_title>Establishment of Abbreviated Pancreatobiliary MRI Using Compressed Sensing Technique for Pancreas Cystic Neoplasm Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to establish abbreviated PB MRI protocol for patients on regular imaging
      follow-up for pancreas cystic neoplasm.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 5, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">November 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Table time of Abbreviated PB MRI</measure>
    <time_frame>1 day after PB MRI acquisition</time_frame>
    <description>total scan time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In room time of Abbreviated PB MRI</measure>
    <time_frame>1 day after PB MRI acquisition</time_frame>
    <description>time spent in room by participants (difference between walk-in and walk-out times)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic confidence</measure>
    <time_frame>6 months after participants enrollment</time_frame>
    <description>subjective diagnostic confidence for pancreas cystic neoplasm on five point scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Image quality</measure>
    <time_frame>6 months after participants enrollment</time_frame>
    <description>overall image quality of Abbreviated PB MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Requirement for re-examination</measure>
    <time_frame>6 months after participants enrollment</time_frame>
    <description>clinical need for re-examination due to suboptimal image quality</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Pancreas Cyst</condition>
  <condition>Intraductal Papillary Mucinous Neoplasm</condition>
  <arm_group>
    <arm_group_label>Follow-up participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who met eligibility criteria. Participants are going to undergo Abbreviated PB MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Abbreviated PB MRI</intervention_name>
    <description>Abbreviated PB MRI which targets table time of 10 minutes. For MRI acquisition, standard dose of commercially available MR contrast agent (Gadovist, Bayer, Germany) is used on weight-based dosing (0.1mmol/kg).</description>
    <arm_group_label>Follow-up participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  on follow-up for pancreas intraductal mucinous neoplasm

          -  OR incidentally detected pancreas cyst (equal to or larger than 1cm)

          -  AND scheduled for CECT or has CECT within a months

          -  AND sign informed consent

        Exclusion Criteria:

          -  Any absolute or relative contra-indication for contrast-enhanced MRI

          -  No pancreas cystic neoplasm

          -  History of pancreatectomy

          -  History of any procedure for pancreatic cyst (ablation, aspiration...) in a year

          -  Hemosiderosis

          -  Suspicion of acute pancreatitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeong Hee Yoon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 3, 2018</study_first_submitted>
  <study_first_submitted_qc>November 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>December 10, 2019</last_update_submitted>
  <last_update_submitted_qc>December 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong Hee Yoon</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Cyst</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

